Comparability of input parameters in the German Retina.net ROP registry and the EU-ROP registry - An exemplary comparison between 2011 and 2021.
ROP
anti-VEGF
laser coagulation
observational study
registry
retinopathy of prematurity
Journal
Acta ophthalmologica
ISSN: 1755-3768
Titre abrégé: Acta Ophthalmol
Pays: England
ID NLM: 101468102
Informations de publication
Date de publication:
19 Sep 2023
19 Sep 2023
Historique:
revised:
04
07
2023
received:
19
04
2023
accepted:
29
08
2023
medline:
19
9
2023
pubmed:
19
9
2023
entrez:
19
9
2023
Statut:
aheadofprint
Résumé
The German Retina.net ROP registry and its Europe-wide successor, the EU-ROP registry, collect data from patients treated for ROP. This analysis compares input parameters of these two registries to establish a procedure for joint analyses of different registry data using exemplary datasets from the two registries. Exemplary datasets from the two databases over a 1-year period each (German Retina.net ROP Registry, 2011, 22 infants; EU-ROP Registry, 2021, 44 infants) were compared. The parameters documented in the two databases were aligned and analysed regarding demographic parameters, treatment modalities, complications within first 24 h and retreatments. The current analysis showed that data can be aligned for joint analyses with some adjustments within the data structure. The registry with more detailed data collection (EU-ROP) needs to be reduced regarding granularity in order to align the different registries, as the registry with lower granularity determines the level of analyses that can be performed in a comparative approach. In the exemplary datasets, we observed that the overall most common ROP severity in both registries was zone II, 3+ (2011: 70.5%; 2021: 65%), with decreasing numbers of clock hours showing preretinal neovascularisations (2011: 10-12 clock hours in 29% of cases, 2021: 4-6 clock hours in 38%). The most prevalent treatment method was laser coagulation in 2011 (75%) and anti-VEGF therapy in 2021 (86.1%). Within the anti-VEGF group, all patients were treated with bevacizumab in 2011 and with ranibizumab in 2021. Retreatment rates were comparable in 2011 and 2021. Data from two different ROP registries can be aligned and jointly analysed. The analysis reveals a paradigm shift in treatment modalities, from predominantly laser to anti-VEGF, and within the anti-VEGF group from bevacizumab to ranibizumab in Germany. In addition, there was a trend towards earlier treatment in 2021.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Bayer
Organisme : Novartis
Informations de copyright
© 2023 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.
Références
Akman, S.H., Pfeil, J.M., Stahl, A., Ehlers, S., Böhne, C., Bohnhorst, B. et al. (2022) Epidemiologie und Therapie der behandlungsbedürftigen Frühgeborenenretinopathie. Die Hannoveraner Daten im Retina.net ROP-Register von 2001 bis 2017. Der Ophthalmologe, 119, 497-505.
Chiang, M.F., Quinn, G.E., Fielder, A.R., Ostmo, S.R., Paul Chan, R.V., Berrocal, A. et al. (2021) International classification of retinopathy of prematurity, third edition. Ophthalmology, 128, e51-e68.
Chmielarz-Czarnocińska, A., Pawlak, M., Szpecht, D., Choręziak, A., Szymankiewicz-Bręborowicz, M. & Gotz-Więckowska, A. (2021) Management of retinopathy of prematurity (ROP) in a polish cohort of infants. Scientific Reports, 11, 4522.
Deutsche Ophthalmologische Gesellschaft e. V. (DOG), Retinologische Gesellschaft e. V. (RG), & Berufsverband der Augenärzte Deutschlands e. V. (BVA). (2020) Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbands der Augenärzte Deutschlands zur Anti-VEGF-Therapie der Frühgeborenenretinopathie. Der Ophthalmologe, 117, 873-885.
EMA.Europa.eu. (2022) Lucentis 10 mg/mL solution for injection SmPC.
EMA.Europa.eu. (2023) Eylea 40 mg/mL solution for injection in pre-filled syringe SmPC.
Good, W.V. (2004) Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Transactions of the American Ophthalmological Society, 102, 233-250.
Hartnett, M.E. (2017) Advances in understanding and management of retinopathy of prematurity. Survey of Ophthalmology, 62, 257-276.
Holmström, G., Hellström, A., Gränse, L., Saric, M., Sunnqvist, B., Wallin, A. et al. (2020) New modifications of Swedish ROP guidelines based on 10-year data from the SWEDROP register. The British Journal of Ophthalmology, 104, 943-949.
Holmström, G., Tornqvist, K., Al-Hawasi, A., Nilsson, Å., Wallin, A. & Hellström, A. (2018) Increased frequency of retinopathy of prematurity over the last decade and significant regional differences. Acta Ophthalmologica, 96, 142-148.
Larsen, P.P., Müller, A., Lagrèze, W.A., Holz, F.G., Stahl, A. & Krohne, T.U. (2021) Incidence of retinopathy of prematurity in Germany: Evaluation of current screening criteria. Archives of Disease in Childhood. Fetal and Neonatal Edition, 106, 189-193.
Lorenz, B. (2008) Aktuelle augenärztliche Aspekte der akuten Retinopathia praematurorum. Der Ophthalmologe, 105, 1092-1100.
Mintz-Hittner, H.A. (2011) Efficacy of Intravitreal bevacizumab for stage 3+ retinopathy of prematurity. The New England Journal of Medicine, 13, 603-615.
Pfeil, J. (2021) The German ROP registry - data from treated retinopathy of prematurity between 2011 and 2020. Presented at the prize papers 12: Vascular Diseases & Diabetic Retinopathy III, EURETINA (digital).
Pfeil, J.M. & Stahl, A. (2022) EUR-ROP: Das neu etablierte europäische Register für Frühgeborenenretinopathie. Zeitschrift für Praktische Augenheilkunde, 43, 266-270.
Pivodic, A., Nilsson, S., Stahl, A., Smith, L.E.H. & Hellström, A. (2021) Validation of the retinopathy of prematurity activity scale (ROP-ActS) using retrospective clinical data. Acta Ophthalmologica, 99, 201-206.
Retina.net ROP-Register-Studiengruppe, Walz, J.M., Bemme, S., Reichl, S., Akman, S., Breuß, H. et al. (2018) Behandelte Frühgeborenenretinopathie in Deutschland: 5-Jahres-Daten des Retina.net ROP-Registers. Der Ophthalmologe, 115, 476-488.
Solebo, A.L., Teoh, L., Sargent, J., Rahi, J.S. & British Childhood Visual Impairment and Blindness Study Interest Group (2022) Avoidable childhood blindness in a high-income country: findings from the British Childhood Visual Impairment and Blindness Study 2. The British Journal of Ophthalmology. Available from: https://doi.org/10.1136/bjo-2022-321718
Stahl, A., Krohne, T.U., Eter, N., Oberacher-Velten, I., Guthoff, R., Meltendorf, S. et al. (2018) Comparing alternative Ranibizumab dosages for safety and efficacy in retinopathy of prematurity: A randomized clinical trial. JAMA Pediatrics, 172, 278-286.
Stahl, A., Krohne, T.U. & Limburg, E. (2012) Register zur Erfassung behandlungsbedürftiger Frühgeborenenretinopathie. Zeitschrift für Praktische Augenheilkunde, 5, 500-504.
Stahl, A., Lepore, D., Fielder, A., Fleck, B., Reynolds, J.D., Chiang, M.F. et al. (2019) Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): An open-label randomised controlled trial. The Lancet, 394, 1551-1559.
Stahl, A., Sukgen, E.A., Wu, W.-C., Lepore, D., Nakanishi, H., Mazela, J. et al. (2022) Effect of intravitreal aflibercept vs laser photocoagulation on treatment success of retinopathy of prematurity: The FIREFLEYE Randomized clinical trial. JAMA, 328, 348-359.
UK Retinopathy of Prematurity Special Interest Group, Adams, G.G., Bunce, C., Xing, W., Butler, L., Long, V. et al. (2018) Retinopathy of prematurity in the United Kingdom: Retreatment rates, visual and structural 1-year outcomes. Eye, 32, 1752-1759.
Voigt, M., Rochow, N., Schneider, K., Hagenah, H.P., Scholz, R., Hesse, V. et al. (2014) Neue Perzentilwerte für die Körpermaße neugeborener Einlinge: Ergebnisse der deutschen Perinatalerhebung der Jahre 2007-2011 unter Beteiligung aller 16 Bundesländer. Zeitschrift für Geburtshilfe Und Neonatologie, 218, 210-217.
Walz, J.M., Bemme, S., Pielen, A., Aisenbrey, S., Breuß, H., Alex, A.F. et al. (2016) The German ROP registry: Data from 90 infants treated for retinopathy of prematurity. Acta Ophthalmologica, 94, e744-e752.